.png)
.png)
Is it time for a new tool box for drug research and development?
In this blog, Professor James Fildes, CEO and Chief Scientist and Amy Stewart, Research Technician at Pebble Biotechnology Laboratories argue that the significant difference in human to mice gene expression in various tissues could explain why many drugs that are successful in rodents fail in humans.
Cambridge Wide Open Day to drive inclusive collaboration
o2h group launches the Cambridge Wide Open Day, offering a unique insight into the city best known as the ‘UK Centre of Science & Technology’.
Stablepharma and BB-NCIPD Ltd (Bul Bio) to develop a fridge-free Tetanus mono vaccine.
Stablepharma Ltd. and BB-NCIPD Ltd. (Bul Bio) have signed a second agreement for the exclusive bulk supply and commercialization of the Tetanus vaccine (SPVX06), following a similar arrangement for the Tetanus diphtheria vaccine (SPVX02) last year.
CEO Update - 30 May 2023
Last Thursday was a big day for our sector as government and industry leaders came together for the UK Life Science Council meeting in No 10 Downing Street. It’s the pinnacle of the partnership working – forged and deepened through our joint work in the pandemic – and the BIA was at the heart of the action-progressing key agendas on behalf of members.
Member spotlight: supercharging drug discovery with Carterra
In our latest member spotlight blog, Josh Eckman, Founder and CEO of Carterra, details the Carterra's journey, from disrupting an already established industry as a start-up, to assisting in the development of the first Covid19 therapeutic antibody.
BIA welcomes Chancellor’s life sciences growth package
The UK Government has announced a package of investment and policy initiatives to support the continued growth of the sector following a meeting of the Chancellor, Jeremy Hunt MP, and industry leaders in Downing Street.
Coulter Partners announces Gerben van 't Klooster as chief development officer at TargED Biopharmaceuticals
Coulter Partners, is pleased to announce the placement of Gerben van 't Klooster as Chief Development Officer (CDO) of TargED Biopharmaceuticals.
Discovery Park and EKC Group join forces to boost STEM careers in Kent
A partnership has been forged between Discovery Park and EKC Group, a further education provider, to inspire more of Kent’s young people to experience a career in science, technology, engineering and maths.
Touchlight creates world’s largest DNA manufacturing facilities in London, UK
- Facility will have capacity that exceeds today’s global plasmid DNA demand and can enable commercialisation of genetic medicines. Supplying many of the top biopharmaceutical companies in the world.
In2scienceUK, promoting diversity and inclusion within STEM
In2scienceUK is a charity that empowers young people from low-income backgrounds to reach their potential and progress to careers in Science, Technology, Engineering and Mathematics (STEM)